|
시장보고서
상품코드
2056404
군유전체학 시장 보고서 : 제품별, 기술별, 용도별, 지역별(2026-2034년)Metagenomics Market Report by Product, Technology, Application, and Region 2026-2034 |
||||||
세계의 군유전체학 시장 규모는 2025년에 6억 7,760만 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 15억 1,610만 달러에 달하며, 2026-2034년에 CAGR 9.08%로 성장할 것으로 예측하고 있습니다.
메타게놈학은 자연환경의 미생물 유전체 연구를 말합니다. 이는 개별 종을 분리하거나 실험실에서 배양할 필요 없이 게놈을 복제하여 생태, 진화, 다양성을 연구하는 것을 포함합니다. 메타게놈은 시퀀싱 및 생물정보학 기술을 이용하여 과학적 지식을 얻고 있으며, 물, 토양 및 인간의 배설물을 통해 환경 시료에서 채취한 데옥시리보핵산(DNA)을 분석하기 위한 분자 툴로 활용되고 있습니다. 샘플은 시퀀싱 리드, 유전자 예측, 비닝, 기능적 어노테이션을 통해 추가적으로 처리됩니다. 이를 통해 얻은 지식은 감염병 진단, 환경 복원, 장내 미생물 특성 평가, 바이오 연료 개발 등에 활용되고 있습니다.
메타게놈 시장 동향:
설사, 독감, B형 간염, HIV/AIDS와 같은 바이러스성 감염증이 전 세계에서 증가하고 있는 것이 시장 성장을 이끄는 주요 요인 중 하나입니다. 또한 수막염이나 뇌염과 같은 신경 감염을 신속하게 진단할 수 있는 효과적인 솔루션에 대한 수요가 증가하면서 시장 성장을 촉진하고 있습니다. 이에 따라 군유전체학은 식중독 발생을 유발하는 세균성 병원체를 규명하는 데에도 도움을 주며 시장 성장에 더욱 기여하고 있습니다. 기존 기술에 비해 메타게놈은 시퀀싱 전 전처리 공정이 적고, 롱리드의 신뢰성을 높이고, 높은 리드 정확도를 제공합니다. 또한 차세대 시퀀싱 서비스 개발 등 다양한 기술 발전도 시장 성장을 촉진하는 요인으로 작용하고 있습니다. 이러한 솔루션은 데이터 분석 소프트웨어와 통합되어 데이터 분석 및 시료 처리 속도를 높입니다. 또한 생명과학 분야의 광범위한 연구개발(R&D) 활동과 지속가능한 농산물 생산을 위한 메타게놈학의 활용 확대 등 다른 요인들도 시장 성장을 촉진할 것으로 예상됩니다.
이 보고서에서 답변하는 주요 질문:
- 지금까지의 글로벌 메타게놈 시장 동향은 어떠했으며, 향후 수년간 어떻게 변화하는가?
- COVID-19는 전 세계 메타게놈 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은 어디인가?
- 제품별로 보면 시장 분석은 어떻게 이루어지는가?
- 기술별 시장 현황은?
- 용도에 따른 시장 내역은?
- 이 산업의 밸류체인에서 각 단계는 어떤 역할을 하는가?
- 이 산업의 주요 촉진요인과 과제는 무엇인가?
- 세계의 메타 유전체학 시장의 구조는 무엇이며, 주요 기업은 어디인가?
- 업계내 경쟁은 어느 정도 치열한가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 군유전체학 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 기술별
제8장 시장 내역 : 용도별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSA 26.06.16The global metagenomics market size reached USD 677.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,516.1 Million by 2034, exhibiting a growth rate (CAGR) of 9.08% during 2026-2034.
Metagenomics refers to the study of microbial genomes in the natural environment. It involves cloning of the genome to study the ecology, evolution and diversity, thereby bypassing the need for isolation and laboratory cultivation of individual species. Metagenomics uses sequencing and bioinformatics technologies to obtain scientific insights and is utilized as a molecular tool for analyzing the deoxyribonucleic acid (DNA) acquired from the environmental samples through water, soil and human waste. The samples are further processed through sequence reading, gene prediction, binning and functional annotation. The insights are used to diagnose infectious diseases, environmental remediation, gut microbe characterization and the development of biofuels.
Metagenomics Market Trends:
The increasing prevalence of virus-induced infections, such as diarrhea, influenza, hepatitis B, and HIV/AIDS, across the globe, is among the key factors driving the market growth. Moreover, the rising demand for effective solutions for the timely diagnosis of neuroinfectious diseases, such as meningitis and encephalitis, is providing a thrust to the market growth. In line with this, metagenomics also aids in identifying bacterial pathogens that can lead to foodborne disease outbreaks, which is further contributing to the growth of the market. In comparison to the traditionally used technologies, metagenomics requires a lesser number of pre-sequencing steps, enhances the authenticity of long readings and offers high read accuracy. Additionally, various technological advancements, such as the development of next-generation sequencing services, are acting as other growth-inducing factors. These solutions are integrated with data analysis software for faster data analysis and sample processing. Other factors, including extensive research and development (R&D) activities in the field of life sciences, along with the increasing utilization of metagenomics for manufacturing sustainable agricultural products, are anticipated to drive the market toward growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global metagenomics market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on product, technology and application.
Breakup by Product:
- Instruments and Software
- Consumables
Breakup by Technology:
- Sequencing
- Bioinformatics
Breakup by Application:
- Infectious Disease Diagnosis
- Environmental Remediation
- Gut Microbe Characterization
- Biotechnology
- Biofuel
- Agriculture
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc, Enterome, Eurofins Scientific, F. Hoffmann-La Roche AG (Roche Holding AG), Illumina Inc, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. (Danaher Corporation) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global metagenomics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global metagenomics market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global metagenomics market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Metagenomics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Instruments and Software
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Consumables
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Sequencing
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Bioinformatics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Infectious Disease Diagnosis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Environmental Remediation
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Gut Microbe Characterization
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Biotechnology
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Biofuel
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Agriculture
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Agilent Technologies Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Enterome
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Eurofins Scientific
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 F. Hoffmann-La Roche AG (Roche Holding AG)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 Illumina Inc
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Novogene Co. Ltd.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Oxford Nanopore Technologies Limited
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 SWOT Analysis
- 14.3.8 Pacific Biosciences of California Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 PerkinElmer Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 QIAGEN N.V.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Swift Biosciences Inc. (Danaher Corporation)
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Thermo Fisher Scientific Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.1 Agilent Technologies Inc.
